Iranian baby with heart defect admitted to Portland hospital

Iranian baby with heart defect admitted to Portland hospital

An Iranian infant in need of life-saving heart surgery, who was temporarily banned by President Donald Trump’s immigration order from entering the United States, has finally made it to Portland.

Four-month-old Fatemeh Reshad’s parents told reporters that Iranian doctors told them that their little daughter needed at least one urgent heart surgery to correct heart defects, or she would die.

But, when Fatemah’s parents were on their way to Dubai to fly to the United States for the surgical procedure to save the life of their daughter, President Trump signed the controversial executive order banning visitors and refugees from seven Muslim-majority countries.

Luckily, Gov. Cuomo secured legal assistance for the infant, and a federal court judge granted a temporary injunction on the executive order. On Tuesday, the Iranian infant was admitted to OHSU Doernbecher Children’s Hospital in Portland.

Dr. Laurie Armsby, interim head of the Division of Pediatric Cardiology at the hospital, said, “Fatemeh looks well. Our tests this morning have confirmed her diagnosis and the urgent need for treatment. As we suspected, her heart condition has resulted in injury to her lungs, however the studies today indicate that she has presented to us in time to reverse this process.”

Fatemah is in need of a crucial life-saving heart surgery to fix a number of structural abnormalities and two holes in her heart.

General: 
People: 

Popular Stories

Erosion of beaches will get worse: researchers warn

Portraying a gloomy picture of the future, the 2015... Read More

Rare rat-linked disease leaves 1 dead, 2 sickened in Bronx

A rare bacterial disease carried by rats has killed... Read More

Try drug-free remedies before resorting to medication for low back pain: ACP

People suffering low back pain should try drug-free... Read More

Pregnant inmate forced to deliver baby on jail cell floor

A Detroit-area sheriff has defended his staff over... Read More

Marathon Pharma to sell decades-old drug to treat DMD for $89,000

Marathon Pharmaceuticals will reportedly market... Read More